Radiologically Defined Sarcopenia Affects Survival in Head and Neck Cancer: A Meta-Analysis
- PMID: 32220072
- DOI: 10.1002/lary.28616
Radiologically Defined Sarcopenia Affects Survival in Head and Neck Cancer: A Meta-Analysis
Abstract
Objective: To determine whether radiologically defined sarcopenia at the C3 or L3 level as measured by computed tomography or magnetic resonance imaging is prognostic of overall survival (OS) in head and neck cancers (HNCs).
Methods: Literature searches of PubMed, Embase, and Scopus were conducted on July 12, 2019, to include articles written in the English language with no constraints on publication date. To be included in the analysis, articles had to report the prognostic impact of skeletal muscle mass measured radiologically at the C3 or L3 vertebral level in HNC patients; hazard ratios (HRs) for OS; 95% confidence intervals (CIs); be from a clinical trial, cohort, or case-control study; and have English full-text availability. Articles were reviewed in consensus by two reviewers, with disagreements reviewed by a third reviewer. Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Meta-analysis Of Observational Studies in Epidemiology Checklist guidelines were used for reporting. Study quality assessment was performed using Quality In Prognosis Studies tool. The random-effects DerSimonian and Laird method was used for meta-analysis.
Results: Ten articles, nine retrospective and one prospective, were included in this meta-analysis (n = 2,181 patients). Significant differences were found in OS for HNC patients with sarcopenia (HR = 1.98; 95% CI: 1.64-2.39; P < .00001). No heterogeneity was detected in either the overall or subgroup analyses.
Conclusions: Radiologically defined sarcopenia is a negative predictor of OS in patients with HNC. Early detection of sarcopenia in cancer patients may help guide nutritional and adjuvant support to improve treatment outcomes.
Level of evidence: NA Laryngoscope, 131:333-341, 2021.
Keywords: Head and neck; radiology; sarcopenia; statistics; survival.
© 2020 The American Laryngological, Rhinological and Otological Society, Inc.
Similar articles
-
Prevalence and Association of Sarcopenia with Mortality in Patients with Head and Neck Cancer: A Systematic Review and Meta-Analysis.Ann Surg Oncol. 2024 Sep;31(9):6049-6064. doi: 10.1245/s10434-024-15510-7. Epub 2024 Jun 7. Ann Surg Oncol. 2024. PMID: 38847986
-
The Association Between Computed Tomography-Defined Sarcopenia and Outcomes in Adult Patients Undergoing Radiotherapy of Curative Intent for Head and Neck Cancer: A Systematic Review.J Acad Nutr Diet. 2020 Aug;120(8):1330-1347.e8. doi: 10.1016/j.jand.2020.03.021. J Acad Nutr Diet. 2020. PMID: 32711854
-
Is sarcopenia a predictor of prognosis for patients undergoing radiotherapy for head and neck cancer? A meta-analysis.Clin Nutr. 2021 Apr;40(4):1711-1718. doi: 10.1016/j.clnu.2020.09.017. Epub 2020 Sep 18. Clin Nutr. 2021. PMID: 32994071
-
Sarcopenia and myosteatosis in patients undergoing curative radiotherapy for head and neck cancer: Impact on survival, treatment completion, hospital admission and cost.J Hum Nutr Diet. 2020 Dec;33(6):811-821. doi: 10.1111/jhn.12788. Epub 2020 Jul 1. J Hum Nutr Diet. 2020. PMID: 32609428
-
Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):2187-2198. doi: 10.1002/jcsm.12829. Epub 2021 Oct 21. J Cachexia Sarcopenia Muscle. 2021. PMID: 34676673 Free PMC article.
Cited by
-
Low skeletal muscle mass predicts relevant clinical outcomes in head and neck squamous cell carcinoma. A meta analysis.Ther Adv Med Oncol. 2021 May 13;13:17588359211008844. doi: 10.1177/17588359211008844. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34035838 Free PMC article.
-
Prognostic Value of Sarcopenia in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A Systematic Review and Meta-Analysis.Front Nutr. 2022 Feb 25;9:816883. doi: 10.3389/fnut.2022.816883. eCollection 2022. Front Nutr. 2022. PMID: 35284466 Free PMC article.
-
Enhanced recovery after surgery, current, and future considerations in head and neck cancer.Laryngoscope Investig Otolaryngol. 2023 Sep 4;8(5):1240-1256. doi: 10.1002/lio2.1126. eCollection 2023 Oct. Laryngoscope Investig Otolaryngol. 2023. PMID: 37899849 Free PMC article. Review.
-
Sarcopenia as a Prognostic Factor and Multimodal Interventions in Breast Cancer.Int J Gen Med. 2024 Dec 31;17:6605-6616. doi: 10.2147/IJGM.S497897. eCollection 2024. Int J Gen Med. 2024. PMID: 39764482 Free PMC article.
-
Impact of low skeletal muscle mass and quality on clinical outcomes in patients with head and neck cancer undergoing (chemo)radiation.Front Nutr. 2022 Nov 17;9:994499. doi: 10.3389/fnut.2022.994499. eCollection 2022. Front Nutr. 2022. PMID: 36466387 Free PMC article.
References
BIBLIOGRAPHY
-
- Martin L, Birdsell L, MacDonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013;31:1539-1547.
-
- Villaseñor A, Ballard-Barbash R, Baumgartner K, et al. Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study. J Cancer Surviv 2012;6:398-406.
-
- Rubbieri G, Mossello E, Di Bari M. Techniques for the diagnosis of sarcopenia. Clin Cases Miner Bone Metab 2014;11:181-184.
-
- MacDonald AJ, Greig CA, Baracos V. The advantages and limitations of cross-sectional body composition analysis. Curr Opin Support Palliat Care 2011;5:342-349.
-
- Sato S, Kunisaki C, Suemastu H, et al. Impact of sarcopenia in patients with unresectable locally advanced esophageal cancer receiving chemoradiotherapy. In Vivo 2018;32:603-610.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous